Tag: pharmaceuticals
-
Trial Shows Stem Cell Therapy Slows M.S. Progression
Results of a clinical trial show a treatment for multiple sclerosis from patients’ stem cells slows progression of the disease and improves walking ability.
-
Bayer Gains Lung Cancer Therapy in $670M Deal
Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics.
-
FDA Begins Qualifying Non-Animal Testing Options
The Food and Drug Administration began a pilot program for assessing alternative technologies to test drugs, biologics, and devices without animals.
-
Industry, Univ Labs Partner on Cannabinoid Pain Drug
A Canadian medical school lab is helping evaluate and develop a pain relief drug made by a company developing therapies from cannabis.
-
Crispr Edits Out HIV-Like Genes from Monkey DNA
Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies.
-
Univ, Industry Labs Study Inhaled Covid-19 Antibodies
Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections.
-
Biotech Creating More Efficient Crispr Therapies
A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins.
-
Trial Requested for Covid-19 Vaccine Nasal Spray
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine.
-
Trial Underway Testing Insulin Capsules
Researchers began screening participants for a clinical trial assessing insulin formulated as capsules for people with type 2 diabetes.
-
Natural-Killer Cell Cancer Therapy Biotech Launches
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds.